Blueprint Medicines Corporation today announced that, effective October 1, 2023 , the Compensation Committee of Blueprint Medicines’ Board of Directors granted non-qualified stock options to purchase an aggregate of 3,655 shares of its common stock.
October 5, 2023
· 2 min read